OncoImmune, Inc.;Children's Research Institute, Children's National Medical Center
发明人:
LIU, Yang,ZHENG, Pan,TANG, Fei,LIU, Mingyue,DEVENPORT, Martin,DU, Xuexiang,ZHANG, Yan
申请号：
AU2019216228
公开号：
AU2019216228A1
申请日:
2019.01.29
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present invention relates to compositions of anti-CTLA-4 antibodies that bind to the human CTLA4 molecule and their use in cancer immunotherapy and for the reduction of autoimmune side effects compared to other immunotherapeutic agents.
